top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
1. : Drugs in cardiology / edited by Ephraim Donoso
1. : Drugs in cardiology / edited by Ephraim Donoso
Pubbl/distr/stampa New York [etc.], : Stratton intercontinental Medical book corporation, 1975
Descrizione fisica v. ; 24 cm
Disciplina 615.71
Soggetto topico Farmaci cardiovascolari
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto <1.> : XII, 240 p. ; <2.> : VI, 194 p. : ill.
Record Nr. UNISA-990002117090203316
New York [etc.], : Stratton intercontinental Medical book corporation, 1975
Materiale a stampa
Lo trovi qui: Univ. di Salerno
Opac: Controlla la disponibilità qui
Advances in the Diagnosis of Coronary Atherosclerosis / / edited by Suna Kirac
Advances in the Diagnosis of Coronary Atherosclerosis / / edited by Suna Kirac
Pubbl/distr/stampa [Place of publication not identified] : , : IntechOpen, , 2011
Descrizione fisica 1 online resource (392 pages)
Disciplina 615.71
Soggetto topico Cardiovascular pharmacology
ISBN 953-51-6561-5
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910138163203321
[Place of publication not identified] : , : IntechOpen, , 2011
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
American journal of cardiovascular drugs : drugs, devices and other interventions
American journal of cardiovascular drugs : drugs, devices and other interventions
Pubbl/distr/stampa [Mairangi Bay, Auckland, N.Z.], : Adis International
Descrizione fisica 1 online resource (volumes) : illustrations
Disciplina 615.71
Soggetto topico Cardiovascular agents
Cardiovascular system - Diseases - Treatment
Cardiovascular Agents - therapeutic use
Cardiology - instrumentation
Cardiovascular Diseases - therapy
Heart Diseases - drug therapy
Agents cardiovasculaires
Appareil cardiovasculaire - Maladies - Traitement
Soggetto genere / forma Periodical
Periodicals.
ISSN 1179-187X
Formato Materiale a stampa
Livello bibliografico Periodico
Lingua di pubblicazione eng
Record Nr. UNISA-996218571003316
[Mairangi Bay, Auckland, N.Z.], : Adis International
Materiale a stampa
Lo trovi qui: Univ. di Salerno
Opac: Controlla la disponibilità qui
American journal of cardiovascular drugs : drugs, devices and other interventions
American journal of cardiovascular drugs : drugs, devices and other interventions
Pubbl/distr/stampa [Mairangi Bay, Auckland, N.Z.], : Adis International
Descrizione fisica 1 online resource (volumes) : illustrations
Disciplina 615.71
Soggetto topico Cardiovascular agents
Cardiovascular system - Diseases - Treatment
Cardiovascular Agents - therapeutic use
Cardiology - instrumentation
Cardiovascular Diseases - therapy
Heart Diseases - drug therapy
Agents cardiovasculaires
Appareil cardiovasculaire - Maladies - Traitement
Soggetto genere / forma Periodical
Periodicals.
ISSN 1179-187X
Formato Materiale a stampa
Livello bibliografico Periodico
Lingua di pubblicazione eng
Record Nr. UNINA-9910154543203321
[Mairangi Bay, Auckland, N.Z.], : Adis International
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Basi farmacologiche della terapia cardiovascolare / Fabrizio Ledda ...[et al.]
Basi farmacologiche della terapia cardiovascolare / Fabrizio Ledda ...[et al.]
Pubbl/distr/stampa Torino : UTET, c2000
Descrizione fisica XVIII, 269 p. ; 26 cm.
Disciplina 615.71
Soggetto topico Medicinali cardiovascolari
Apparato circolatorio - Malattie - Farmacoterapia
ISBN 88-02-05684-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione ita
Record Nr. UNISA-990000318290203316
Torino : UTET, c2000
Materiale a stampa
Lo trovi qui: Univ. di Salerno
Opac: Controlla la disponibilità qui
Cardiac drug safety [[electronic resource] ] : a bench to bedside approach / / Matthew J. Killeen
Cardiac drug safety [[electronic resource] ] : a bench to bedside approach / / Matthew J. Killeen
Autore Killeen Matthew J
Pubbl/distr/stampa Singapore, : World Scientific Pub. Co., 2012
Descrizione fisica 1 online resource (189 p.)
Disciplina 363.738/74
363.73874
615.71
Soggetto topico Cardiovascular agents
Soggetto genere / forma Electronic books.
ISBN 1-280-66922-5
9786613646156
981-4317-46-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Contents; Foreword; "Et causae quoque aestimatio saepe morbum solvit"* [Celsus: Prooemium 69, De Medicina]; Preface; Chapter 1 Challenges Facing the Pharmaceutical Industry in the 21st Century; Introduction; The Impact of Cardiac Toxicity on the Pharmaceutical Industry; References; Chapter 2 The Cellular Basis of Cardiac Electrophysiology; Introduction; The Initiation of the Heart Beat; The Ventricular Cardiac Action Potential; The Relationship Between the Cardiac Action Potential and the Electrocardiogram; Ion Channels Underlying the Cardiac Action Potential; Sodium channels
Calcium channels Potassium channels; Cardiac potassium channels; The transient outward potassium channel; Delayed rectifier potassium channels; The ultra rapid delayed rectifier potassium channel; The HERG potassium channel; The slowly activating delayed rectifier potassium channel; Inwardly rectifying potassium channels; Species-dependent variability of potassium channels; Potassium channel subunits; Summary; References; Chapter 3 Clinical Arrhythmia Syndromes; Introduction; The Long QT Syndrome; Congenital Long QT Syndrome; Drug-Induced QT Prolongation; Summary; References
Chapter 4 The Mechanisms Underlying Cardiac Arrhythmias Introduction; Mechanisms Underlying Cardiac Arrhythmias; Abnormal Automaticity; Early and Delayed After depolarizations; Re-entry; Transmural Dispersion of Repolarization; How does Action Potential and QT Prolongation Generate Arrhythmias?; Does the M-Cell Play a Role in Arrhythmia Induction in Humans?; Using Mouse Models to Study Arrhythmia Mechanisms; Experimental Studies Exploring the Relationship Between Changes in Transmural Repolarization Gradients and Arrhythmias in Mouse Hearts
Arrhythmia Mechanisms and Novel Antiarrhythmic Approaches Identified Using the Hypokalemic Mouse Model Summary; References; Chapter 5 The Mechanisms Underlying Drug-Induced Arrhythmias; Introduction; The Classical Model of Drug-Induced QT Prolongation and Proarrhythmia: HERG Blockade; Additional Mechanisms Contributing to Drug-Induced Arrhythmias; Drug-Induction Activation of Depolarizing Ion Channels; Drug-Induced Changes in Ion Channel Expression; Drug-Induced Sodium Channel Dysfunction; Summary; References; Chapter 6 Assessing Cardiac Safety in Drug Development; Introduction
Preclinical Evaluation of Cardiac Drug Safety The ICH S7B Guidelines; Single Cell Safety Studies; The Purkinje Fiber Model; The Ventricular Wedge Model; Isolated Heart Models; In Vivo Models; The Impact of Species-Related Differences in Cardiac Electrophysiology on Preclinical Drug Safety Assessment; Methods to Provoke Arrhythmias in Preclinical Studies; Programmed electrical stimulation; Reductions in the extracellular K+ concentration; Clinical Evaluation of Cardiac Safety; The Thorough QT study; Thorough QT study design; Additional Biomarkers to Detect Drug-Induced Proarrhythmia
Variability of repolarization
Record Nr. UNINA-9910451573503321
Killeen Matthew J  
Singapore, : World Scientific Pub. Co., 2012
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cardiac drug safety [[electronic resource] ] : a bench to bedside approach / / Matthew J. Killeen
Cardiac drug safety [[electronic resource] ] : a bench to bedside approach / / Matthew J. Killeen
Autore Killeen Matthew J
Pubbl/distr/stampa Singapore, : World Scientific Pub. Co., 2012
Descrizione fisica 1 online resource (189 p.)
Disciplina 363.738/74
363.73874
615.71
Soggetto topico Cardiovascular agents
ISBN 1-280-66922-5
9786613646156
981-4317-46-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Contents; Foreword; "Et causae quoque aestimatio saepe morbum solvit"* [Celsus: Prooemium 69, De Medicina]; Preface; Chapter 1 Challenges Facing the Pharmaceutical Industry in the 21st Century; Introduction; The Impact of Cardiac Toxicity on the Pharmaceutical Industry; References; Chapter 2 The Cellular Basis of Cardiac Electrophysiology; Introduction; The Initiation of the Heart Beat; The Ventricular Cardiac Action Potential; The Relationship Between the Cardiac Action Potential and the Electrocardiogram; Ion Channels Underlying the Cardiac Action Potential; Sodium channels
Calcium channels Potassium channels; Cardiac potassium channels; The transient outward potassium channel; Delayed rectifier potassium channels; The ultra rapid delayed rectifier potassium channel; The HERG potassium channel; The slowly activating delayed rectifier potassium channel; Inwardly rectifying potassium channels; Species-dependent variability of potassium channels; Potassium channel subunits; Summary; References; Chapter 3 Clinical Arrhythmia Syndromes; Introduction; The Long QT Syndrome; Congenital Long QT Syndrome; Drug-Induced QT Prolongation; Summary; References
Chapter 4 The Mechanisms Underlying Cardiac Arrhythmias Introduction; Mechanisms Underlying Cardiac Arrhythmias; Abnormal Automaticity; Early and Delayed After depolarizations; Re-entry; Transmural Dispersion of Repolarization; How does Action Potential and QT Prolongation Generate Arrhythmias?; Does the M-Cell Play a Role in Arrhythmia Induction in Humans?; Using Mouse Models to Study Arrhythmia Mechanisms; Experimental Studies Exploring the Relationship Between Changes in Transmural Repolarization Gradients and Arrhythmias in Mouse Hearts
Arrhythmia Mechanisms and Novel Antiarrhythmic Approaches Identified Using the Hypokalemic Mouse Model Summary; References; Chapter 5 The Mechanisms Underlying Drug-Induced Arrhythmias; Introduction; The Classical Model of Drug-Induced QT Prolongation and Proarrhythmia: HERG Blockade; Additional Mechanisms Contributing to Drug-Induced Arrhythmias; Drug-Induction Activation of Depolarizing Ion Channels; Drug-Induced Changes in Ion Channel Expression; Drug-Induced Sodium Channel Dysfunction; Summary; References; Chapter 6 Assessing Cardiac Safety in Drug Development; Introduction
Preclinical Evaluation of Cardiac Drug Safety The ICH S7B Guidelines; Single Cell Safety Studies; The Purkinje Fiber Model; The Ventricular Wedge Model; Isolated Heart Models; In Vivo Models; The Impact of Species-Related Differences in Cardiac Electrophysiology on Preclinical Drug Safety Assessment; Methods to Provoke Arrhythmias in Preclinical Studies; Programmed electrical stimulation; Reductions in the extracellular K+ concentration; Clinical Evaluation of Cardiac Safety; The Thorough QT study; Thorough QT study design; Additional Biomarkers to Detect Drug-Induced Proarrhythmia
Variability of repolarization
Record Nr. UNINA-9910779277703321
Killeen Matthew J  
Singapore, : World Scientific Pub. Co., 2012
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cardiac drug safety [[electronic resource] ] : a bench to bedside approach / / Matthew J. Killeen
Cardiac drug safety [[electronic resource] ] : a bench to bedside approach / / Matthew J. Killeen
Autore Killeen Matthew J
Edizione [1st ed.]
Pubbl/distr/stampa Singapore, : World Scientific Pub. Co., 2012
Descrizione fisica 1 online resource (189 p.)
Disciplina 363.738/74
363.73874
615.71
Soggetto topico Cardiovascular agents
ISBN 1-280-66922-5
9786613646156
981-4317-46-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Contents; Foreword; "Et causae quoque aestimatio saepe morbum solvit"* [Celsus: Prooemium 69, De Medicina]; Preface; Chapter 1 Challenges Facing the Pharmaceutical Industry in the 21st Century; Introduction; The Impact of Cardiac Toxicity on the Pharmaceutical Industry; References; Chapter 2 The Cellular Basis of Cardiac Electrophysiology; Introduction; The Initiation of the Heart Beat; The Ventricular Cardiac Action Potential; The Relationship Between the Cardiac Action Potential and the Electrocardiogram; Ion Channels Underlying the Cardiac Action Potential; Sodium channels
Calcium channels Potassium channels; Cardiac potassium channels; The transient outward potassium channel; Delayed rectifier potassium channels; The ultra rapid delayed rectifier potassium channel; The HERG potassium channel; The slowly activating delayed rectifier potassium channel; Inwardly rectifying potassium channels; Species-dependent variability of potassium channels; Potassium channel subunits; Summary; References; Chapter 3 Clinical Arrhythmia Syndromes; Introduction; The Long QT Syndrome; Congenital Long QT Syndrome; Drug-Induced QT Prolongation; Summary; References
Chapter 4 The Mechanisms Underlying Cardiac Arrhythmias Introduction; Mechanisms Underlying Cardiac Arrhythmias; Abnormal Automaticity; Early and Delayed After depolarizations; Re-entry; Transmural Dispersion of Repolarization; How does Action Potential and QT Prolongation Generate Arrhythmias?; Does the M-Cell Play a Role in Arrhythmia Induction in Humans?; Using Mouse Models to Study Arrhythmia Mechanisms; Experimental Studies Exploring the Relationship Between Changes in Transmural Repolarization Gradients and Arrhythmias in Mouse Hearts
Arrhythmia Mechanisms and Novel Antiarrhythmic Approaches Identified Using the Hypokalemic Mouse Model Summary; References; Chapter 5 The Mechanisms Underlying Drug-Induced Arrhythmias; Introduction; The Classical Model of Drug-Induced QT Prolongation and Proarrhythmia: HERG Blockade; Additional Mechanisms Contributing to Drug-Induced Arrhythmias; Drug-Induction Activation of Depolarizing Ion Channels; Drug-Induced Changes in Ion Channel Expression; Drug-Induced Sodium Channel Dysfunction; Summary; References; Chapter 6 Assessing Cardiac Safety in Drug Development; Introduction
Preclinical Evaluation of Cardiac Drug Safety The ICH S7B Guidelines; Single Cell Safety Studies; The Purkinje Fiber Model; The Ventricular Wedge Model; Isolated Heart Models; In Vivo Models; The Impact of Species-Related Differences in Cardiac Electrophysiology on Preclinical Drug Safety Assessment; Methods to Provoke Arrhythmias in Preclinical Studies; Programmed electrical stimulation; Reductions in the extracellular K+ concentration; Clinical Evaluation of Cardiac Safety; The Thorough QT study; Thorough QT study design; Additional Biomarkers to Detect Drug-Induced Proarrhythmia
Variability of repolarization
Record Nr. UNINA-9910824978503321
Killeen Matthew J  
Singapore, : World Scientific Pub. Co., 2012
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cardiac drugs / / editors, Kanu Chatterjee, Eric J. Topol
Cardiac drugs / / editors, Kanu Chatterjee, Eric J. Topol
Edizione [Second edition.]
Pubbl/distr/stampa New Delhi, [India] : , : Jaypee, The Health Sciences Publisher, , 2015
Descrizione fisica 1 online resource (551 p.)
Disciplina 615.71
Soggetto topico Cardiovascular agents - Physiological effect
Heart - Diseases - Chemotherapy
Soggetto genere / forma Electronic books.
ISBN 93-86150-11-5
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910466220303321
New Delhi, [India] : , : Jaypee, The Health Sciences Publisher, , 2015
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cardiac drugs / / editors, Kanu Chatterjee, Eric J. Topol
Cardiac drugs / / editors, Kanu Chatterjee, Eric J. Topol
Edizione [Second edition.]
Pubbl/distr/stampa New Delhi, [India] : , : Jaypee, The Health Sciences Publisher, , 2015
Descrizione fisica 1 online resource (551 p.)
Disciplina 615.71
Soggetto topico Cardiovascular agents - Physiological effect
Heart - Diseases - Chemotherapy
ISBN 93-86150-11-5
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910798671503321
New Delhi, [India] : , : Jaypee, The Health Sciences Publisher, , 2015
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui